Zurcher Kantonalbank (Zurich Cantonalbank) - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 17 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q3 2023$130,278
-30.7%
23,140
-0.1%
0.00%0.0%
Q2 2023$187,917
+15.8%
23,171
+0.2%
0.00%0.0%
Q1 2023$162,302
-16.2%
23,120
-0.3%
0.00%0.0%
Q4 2022$193,637
+21.8%
23,1900.0%0.00%0.0%
Q3 2022$159,000
-15.9%
23,190
-0.1%
0.00%0.0%
Q2 2022$189,000
-53.1%
23,210
-5.7%
0.00%
-50.0%
Q4 2021$403,00024,6230.00%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q1 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$3,253,6286.54%
VILLERE ST DENIS J & CO LLC 300,173$1,671,9630.14%
PINNACLE ASSOCIATES LTD 478,309$2,664,1810.05%
BENJAMIN F. EDWARDS & COMPANY, INC. 45,050$2540.01%
FNY Investment Advisers, LLC 1,539$80.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,140$130,2780.00%
BROWN ADVISORY INC 74,836$416,8370.00%
Geneos Wealth Management Inc. 750$4,2230.00%
Focused Wealth Management, Inc 242$1,3480.00%
UBS Group AG 5,690$31,6930.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders